Arthro Kinetics Biotechnology GmbH

Founded

2002

Staff

2

Organization type

RDM biotech/pharma

Region

Lower Austria

AKI develops, manufactures, and sells medical implants based on a proprietary 3D biomatrix from collagen type I, which functions as a neutral organ scaffold for different types of cells. AKI is a leader in cell-free biologic implants to regenerate cartilage defects.

R&D:Collagen Biomatrix; 3D Bioprint

Production:CaReS and CaReS-1Step - Cartilage Regeneration Systems cell-loaded and cell-free - variable sizes and dimension.

Services:AKI’s cell-free biologic, CaReS-1S, has been clinical proven to halt the progression of cartilage degeneration far more simply and easily than any other alternative. It is a medical device class III product. CaReS®-1S is the first and only “off-the-shelf” biologic for cartilage repair incorporating a patented collagen type I matrix technology. Simple one step procedure resulting in a superior cost-benefit ratio. It is distributed by AKI throughout the World since 2010.

Sales/Distribution:We are seeking reliable partner worldwide to exploit the full commercial potential of our products and product platforms. Cooperations with the financial ability, sales, marketing and distribution network to leverage Arthro Kinetics proprietary technology into a leading worldwide market position.